8,087 results on '"Arthritis, Psoriatic"'
Search Results
2. A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
3. A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
4. Stronger Together Psoriatic Arthritis Wellness Study
5. Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
6. Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
7. A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE VITAL)
8. A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
9. Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment (AgAIN)
10. An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
11. A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease (STAR)
12. Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database (FLYWAY)
13. A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis (AFFINITY)
14. IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT (IMPACT)
15. Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent (SOLSTICE)
16. A Study of Guselkumab in Participants With Active Psoriatic Arthritis (APEX)
17. A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice (PsABIOnd)
18. A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)
19. Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound? (PsACT-US)
20. A Long-term Extension Study of Ustekinumab in Pediatric Participants (UNITED)
21. INSELMA - a Randomised Controlled Trial (INSELMA-RCT)
22. A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE COMPLETE)
23. Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
24. Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight (TOGETHER-PsA)
25. Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
26. Cytokine Expression in Psoriasis Patients with and Without Joint Involvement (CYNEPSA)
27. A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years with Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
28. Mind Matters: a High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients with Psoriatic Diseases
29. Validation of Handheld Ultrasound Devices in Rheumatology
30. A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
31. An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis (UPtimum-PsA)
32. Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis (CP3)
33. A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis (UP-SPOUT)
34. Korean Post-marketing Surveillance for Xeljanz
35. A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
36. Safety and Efficacy of Fecal Microbiota Transplantation
37. Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
38. Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis
39. Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits (RAPID-PsA)
40. A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis
41. Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy (TEMPLATE)
42. Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis (PEAPOD)
43. Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
44. Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
45. Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
46. Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
47. A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis (UPJOINT)
48. Diet Interventions in Psoriatic Arthritis (DIPSA)
49. Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
50. Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.